Terms of Service & Privacy Policy
By continuing to use this website, you agree to the Terms & Conditions and Privacy Policy.
The NORD Board of Directors includes representatives of NORD Member Organizations as well as individuals who have demonstrated leadership in serving the rare disease patient community.
Kay Holcombe MS, ChairSenior Advisor, Milken InstituteBoard, Critical Path Institute | Susan A. Berry, MDUniversity of Minnesota Medical School |
Leon Eidelman, CFA, TreasurerJP Morgan Chase & Co. | Dennis Jackman, MBA, Vice ChairIndependent Board and Organizational Consultant |
Tom KellyUnitedHealth Group (retired) | Shafali Spurling Jeste, MDChildren’s Hospital Los AngelesUSC Keck School of Medicine |
Jim Palma, SecretaryTargetCancer Foundation | Phillip L. Pearl, MDBoston Children's Hospital |
Mike PorathThe Mighty | Peter L. SaltonstallNational Organization for Rare Disorders |
Sheldon Schuster, Ph.D.Keck Graduate Institute of Applied Health Sciences | Mark Skinner, JDInstitute for Policy Advancement |
Lorna Weir, JDElevate Healthcare |
By continuing to use this website, you agree to the Terms & Conditions and Privacy Policy.